1.
Ravasio R, Mazzi S, Esposito M, Fiorino G, Migliore A. A Budget impact analysis of adalimumab biosimilar: the Italian context: Analisi di budget impact del biosimilare di adalimumab: lo scenario italiano. AboutOpen [Internet]. 2019 May 6 [cited 2024 Nov. 21];5(1):16-23. Available from: https://journals.aboutscience.eu/index.php/aboutopen/article/view/280